Original Research
Accepted on 27 May 2025
KETAMIR-2, A NEW MOLECULAR ENTITY AND NOVEL KETAMINE ANALOG
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1606976
Type at least 3 characters
3,553 articles
Original Research
Accepted on 26 May 2025
Protocatechualdehyde Attenuates Oxidative Stress in Diabetic Cataract via GLO1-Mediated Inhibition of AGEs/RAGE Glycosylation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1586173
Original Research
Accepted on 26 May 2025
Identification and Evaluation of a Pinocembrin Analog as a TRPV1 Inhibitor with Analgesic Properties in Murine Pain Models
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1585181
Brief Research Report
Accepted on 26 May 2025
Patient-Derived Organoids reveal marked heterogeneity in chemosensitivity profiles of colorectal cancer and a potential association with HER2 Status
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620764
Methods
Accepted on 26 May 2025
The flexibility of SABRE, a new quantitative receptor function model, when fitting challenging concentration-effect data
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591761
Original Research
Accepted on 26 May 2025
Endovascular Management of Primary Long-Segment Inferior Vena Cava Occlusion: Treatment Strategies and Clinical Outcomes
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1512157
Review
Accepted on 26 May 2025
Research progress on peptides that inhibit melanin synthesis
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1610623
Original Research
Accepted on 23 May 2025
Decoding the Therapeutic Mechanism of Conocarpus lancifolius in Hepatocellular Carcinoma: Network Pharmacology, Molecular Docking, and LC-MS QTOF Insights
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1582374
- 167 views
Review
Published on 23 May 2025
Research progress in the treatment of non-scarring alopecia: mechanism and treatment
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544068
- 484 views
Original Research
Published on 23 May 2025
Identification of biomarkers and potential drug targets in DFU based on fundamental experiments and multi-omics joint analysis
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561179
- 390 views
Original Research
Published on 23 May 2025
No significant gender differences in driving-related skills following alcohol mixed with energy drinks during an experimental binge-drinking episode
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1581229
- 549 views
Original Research
Accepted on 22 May 2025
Phosphodiesterase 7 (PDE7): A Potential Novel Therapeutic Target in Ovarian Cancer
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566330
- 135 views
Original Research
Accepted on 22 May 2025
Identification of compounds to promote diabetic wound healing based on transcriptome signature
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1576056
- 105 views
Systematic Review
Accepted on 22 May 2025
Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588841
- 210 views
Original Research
Published on 22 May 2025
Repurposing of the small-molecule adrenoreceptor-inhibitor carvedilol for treatment of the fibrotic lung
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534989
- 605 views
Original Research
Published on 22 May 2025
Exploring the molecular mechanisms of huperzine a in the treatment of rosacea through network pharmacology, machine learning, and molecular dynamics simulations
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1586829
- 362 views